HomeSite MapCustomer Logon
 Dialog1
 DialogClassic
 DialogPRO
 DialogSelect
 DialogWeb
 ProQuest Dialog
Authoritative Answers for Professionals
Follow Dialog on Twitter  Follow Dialog on Facebook  Join Dialog on LinkedIn  You Tube e-Newsletters  RSS Feeds  Share

Support : Publications : Chronolog Archives : June 2001

Pharmaprojects Unveils Data Enhancements for 2001

Pharmaprojects (128/PHAR) is pleased to announce details of its editorial enhancements for 2001. These include:

  • An alerting service which highlights updates to data
  • Comprehensive information on indications and status for each drug
  • Coverage of 12 additional countries
  • Changes to the event date

The file has been reloaded on Dialog and DataStar and the following search features are available:

Latest Change Field

Each drug profile contains a section with the following information: the date the profile was updated, regardless of whether it was a major or minor change; initials of the editor who updated the profile; and a summary of the information added. An example of the latest change field is displayed:

20001108 (PN) US approval for    
         non-allergic vaso motor   
         rhinitis reported.

On DataStar, the latest change information is located in the LA field. Use the ..LIMIT command to search for drug profiles updated in the last 6 months:

1_: ANTIHISTAMINE$
2_: ..L LA>20001101

On Dialog, the latest change information is located in the LU field and searchable either by date or by text:

?S LU=20010428 or 
?S LU=TEXT UPDATED BY THROMBOGENICS

Additional Countries

The number of searchable countries has increased to 40. The 12 new countries are:

ChileLuxembourg
ChinaMalaysia
FinlandNew Zealand
Hong KongNorway
IndiaRussia
IsraelThailand

Country and drug status information is located in the CN field on DataStar and the ST field on Dialog.

Linking Indications to Status

In response to customer demand, Pharmaprojects is now linking indications to status. Therapy-status-pharmacology links are already available. For example, users will be able to search for all drugs in Phase II trials for a specific type of cancer (e.g. breast cancer). An example of the latest change field is displayed:

Cancer, lung, Phase III Clinical Trial
 non-small cell 
Cancer, breast Phase II Clinical Trial
Cancer, colorectal Phase II Clinical Trial
Cancer, ovarianPhase II Clinical Trial
Cancer, prostatePhase II Clinical Trial
Cancer, brainPhase II Clinical Trial
Cancer, melanomaPhase II Clinical Trial
Cancer, lymphoma, Phase II Clinical Trial
 non-Hodgkin's 

The indications to status information is located in the IN field on both Dialog and DataStar. On DataStar search as:

1_: (CANCER ADJ BREAST WITH PHASE ADJ II).IN.

On Dialog search as:

?S CANCER(W)BREAST(1W)II/IN

Actual/Estimated Event Date

Pharmaprojects now assigns a specific date to all major events and indicates whether this was, for example, the actual date a drug was launched, or whether the date was estimated by Pharmaprojects. 'Actual' means that Pharmaprojects is certain that the event occurred on the date given or within 15 days before or after the date. The dates are displayed as YYYYMMDD and located in the DT field on DataStar and the UP field on Dialog.

To search on DataStar for major events with an actual date in April 2001, use DT=

1_: 200104$ ADJ ACT.DT.:

On Dialog use UP=:

?S UP=20010401

Pharmaprojects is always interested in receiving feedback from users on suggestions for additional data fields, as well as other comments. This year has seen the inauguration of the Pharmaprojects Editorial Board to provide strong links with data users and the editorial team.

For questions relating to searching Pharmaprojects on Dialog or DataStar, call the Knowledge Center Help line in the U.S. at 1-800-3DIALOG (334-2564) or your local Help Desk.

top

IN THIS ISSUE

Announcements
What's New on the System
Tips on Technique
Workshops, Seminars, Etc.
Documentation
Chronolog Archives

  ProQuest   |   About Us   |   Site Search   |   Site Map  
Copyright Notices   |   Terms of Use   |   Privacy Statement